سعر نيتروفورينال 200مجم 12 كبسول 2022

Nitrofurinal 200 mg nifuroxazide capsules (Pharopharma, Egypt), box of 12; intestinal anti-infective for acute bacterial diarrhoea.

• Acute diarrhoea of presumed bacterial origin in the absence of suspected invasive phenomena (adults)Population: AdultsANSM (Agence nationale de sécurité du médicament et des produits de santé)

• Frequency not known: rash, eczema, acute generalised exanthematous pustulosis, photosensitivity; allergic reactions including urticaria, angioedema and anaphylactic shock; thrombocytopenia, haemolytic anaemia, agranulocytosis; raised transaminases; chromaturia.International label, equivalent formulation · ANSM (Agence nationale de sécurité du médicament et des produits de santé)

• Hypersensitivity to nifuroxazide, nitrofuran derivatives or excipients; children and adolescents under 18 years (French capsule label).International label, equivalent formulation · ANSM (Agence nationale de sécurité du médicament et des produits de santé)

• Rehydration must always be considered; if invasive infection is suspected use systemic antibacterials; reassess if diarrhoea persists after 2 days. French product contains sucrose.International label, equivalent formulation · ANSM (Agence nationale de sécurité du médicament et des produits de santé)
• Stop immediately if hypersensitivity reactions occur (dyspnoea, facial/lip/tongue oedema, rash, itch); avoid alcohol during treatment.General active-ingredient information · Rejestr Produktów Leczniczych (Poland)

• Drugs causing disulfiram-like (antabuse) reactions; CNS depressantsConcomitant use is not recommended.ANSM (Agence nationale de sécurité du médicament et des produits de santé)
• AlcoholDrinking alcohol during treatment may cause disulfiram-like reactions.Rejestr Produktów Leczniczych (Poland)

• No teratogenic effect in animals; clinical data insufficient; as a precaution it is preferable not to use nifuroxazide during pregnancy.International label, equivalent formulation · ANSM (Agence nationale de sécurité du médicament et des produits de santé)
• Polish SmPC: limited human data and possible mutagenic potential; not recommended in pregnancy or in women of child-bearing potential not using effective contraception.General active-ingredient information · Rejestr Produktów Leczniczych (Poland)
• Breastfeeding remains possible during a short course of treatment.International label, equivalent formulation · ANSM (Agence nationale de sécurité du médicament et des produits de santé)

• Nifuroxazide: 5-nitrofuran derivative with local antibacterial action in the intestinal lumen against some Gram-positive (Staphylococcus) and Gram-negative Enterobacteriaceae (Polish SmPC 5.1); absorption is very low with an intact intestinal mucosa (French SmPC 5.2).